Trials / Withdrawn
WithdrawnNCT01994564
Prevalence of Dyschromatopsia in Glaucoma Patients
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Massachusetts Eye and Ear Infirmary · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Glaucoma is a progressive disease resulting in loss of retinal nerve cells and their axons (retinal nerve fibers). Retinal nerve fibers are ordered in a special manner when they enter the optic nerve. Hence, damage to the retinal nerve fibers by glaucoma results in visual field defects at certain locations. Furthermore, the retinal nerve fiber layers from different receptors for different colors are ordered in a special manner as well. Thus, it is possible that glaucomatous damage causes color vision dysfunction (dyschromatopsia). At the moment there is disagreement whether dyschromatopsia occurs at early- to mid-stage or only in end-stage glaucoma. By testing color vision in glaucoma patients the prevalence of dyschromatopsia in glaucoma and in different stages of the disease will be investigated.
Conditions
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-12-01
- Completion
- 2014-01-01
- First posted
- 2013-11-26
- Last updated
- 2013-11-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01994564. Inclusion in this directory is not an endorsement.